India Bharat Health Global Expo 2026
Analysis based on 13 articles · First reported Sep 06, 2026 · Last updated Sep 07, 2026
The expo highlights India's strategic push to upgrade its pharmaceutical industry from generics to higher-value innovative products, potentially boosting investment and exports. This could positively impact Indian pharma companies and related sectors, while signaling a shift in global supply chain dynamics.
Union Commerce Minister Piyush Goyal inaugurated the Bharat Health Global Expo 2026 at Bharat Mandapam, New Delhi, on September 6, 2026. The expo, running from September 7-9, showcases India's healthcare and life-sciences capabilities, with a focus on exports, innovation, and partnerships. Goyal urged the pharmaceutical industry to move beyond generics and invest in R&D, patents, biosimilars, and biotech, emphasizing the need for resilient supply chains and regulatory convergence with developed markets. Other officials, including Jitin Prasada, Rajesh Agrawal, and India — Pharmexcil leaders, echoed the call for value-added products and technology adoption. The expo includes iPHEX 2026, Pharma Mach and Lab Next Expo, Bharat Nutraverse, and SANJEEVANI, with India — Pharmexcil targeting USD 1.4 billion in export business opportunities.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard